Full Text View
Tabular View
No Study Results Posted
Related Studies
A Study of the Effects of Pegvisomant on Growth Hormone Excess in McCune-Albright Syndrome
This study has been completed.
Study NCT00017927   Information provided by National Institutes of Health Clinical Center (CC)
First Received: June 20, 2001   Last Updated: March 3, 2008   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
McCune Albright Syndrome
Polyostotic Fibrous Dysplasia
Additional conditions recognized in this trial
Acromegaly
Fibrous Dysplasia of Bone
Fibrous Dysplasia, Polyostotic
Syndrome
More general conditions related to this trial
Bone Diseases
Bone Diseases, Developmental
Bone Diseases, Endocrine
Brain Diseases
Central Nervous System Diseases
Disease
Endocrine System Diseases
Hyperpituitarism
Hypothalamic Diseases
Musculoskeletal Diseases
Nervous System Diseases
Osteochondrodysplasias
Pathologic Processes
Pituitary Diseases
Interventions listed in this trial
Pegvisomant
Sponsors listed in this trial
National Institute of Dental and Craniofacial Research (NIDCR)


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services